Victoria Song

Or, you know, there's a strong argument that, you know, medication is important and can help when genetic deficiencies or genetic predispositions are not great for you.

But, you know, what's happening in Washington with the discussion towards health tech and wearables,

It informs the features that come out.

It informs why an AI nutrition chatbot in your Garmin app or your ladder strength training app might tell you that you need to eat 135 grams of protein because RFK Jr.

has said that there is a war on protein, even though there is no scientific evidence proving that.

These things are so tightly married together that we can't talk about one without talking about the other.

And I don't think CGMs are bad.

I don't think non-diabetics necessarily using CGMs is inherently bad.

Like people in my situation where you have a predisposition and something starts feeling not right with you, you want to learn early about what's happening.

I don't think that's necessarily wrong.

I just want us all to be hyper aware of what the cost is.

I paid a pretty high cost throughout this experiment.

I got to live and see firsthand how type one diabetics live because this is life or death for them.

It's not life or death for me, at least not in the short term.

It is very much in the short term for them, a life or death technology.

And, you know, I've gotten a lot of feedback from type one diabetics who are just like,

I hate that they're, you know, marketing this widespread just because in the same way that GLPs have been marketed widespread, it makes life harder for us.

We have shortages now.

And I think that's a valuable conversation to have, even as other people are saying, well, you know what, GLPs for addicts, for people who have PCOS like me, for people who have metabolic dysfunction like me, for people who have high cholesterol and all of these things, it also dramatically improves their lives.

So there is so many conversations right now that are happening.